ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Metabolism >Retinoid Receptor Inhibitors >TTNPB (Arotinoid Acid)

TTNPB (Arotinoid Acid)

TTNPB (Arotinoid Acid) Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:TTNPB
CAS:71441-28-6
Purity:98% HPLC Package:5MG;10MG;50MG;100MG,1G,5G
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695
Email: factory@coreychem.com
Products Intro: Product Name:TTNPB (Arotinoid Acid)
CAS:71441-28-6
Purity:>98% HPLC Package:1KG;8USD
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:TTNPB
CAS:71441-28-6
Purity:98.84% Package:2mg;33USD|5mg;52USD|10mg;79USD Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Dideu Industries Group Limited
Tel: +86-29-89586680 +86-15129568250
Email: 1026@dideu.com
Products Intro: Product Name:TTNPB (Arotinoid Acid)
CAS:71441-28-6
Purity:99.9% Package:25kgs/Drum;200kgs/Drum Remarks:FDA GMP CEP Approved Manufacturer
Company Name: Labnetwork lnc.
Tel: +86-27-50766799 +8618062016861
Email: contact@labnetwork.com
Products Intro: Product Name:TTNPB
CAS:71441-28-6
Purity:95% Package:1kg+

TTNPB (Arotinoid Acid) manufacturers

  • TTNPB
  • TTNPB pictures
  • $33.00 / 2mg
  • 2026-04-21
  • CAS:71441-28-6
  • Min. Order:
  • Purity: 99.55%
  • Supply Ability: 10g
  • TTNPB
  • TTNPB pictures
  • $33.00 / 2mg
  • 2026-04-21
  • CAS:71441-28-6
  • Min. Order:
  • Purity: 99.55%
  • Supply Ability: 10g
  • TTNPB (Arotinoid Acid)
  • TTNPB (Arotinoid Acid) pictures
  • $8.00 / 1KG
  • 2020-02-21
  • CAS:71441-28-6
  • Min. Order: 1g
  • Purity: >98% HPLC
  • Supply Ability: kg--ton
TTNPB (Arotinoid Acid) Basic information
Description Uses Biochemical Actions In vitro In vivo DIFFERENTIATION REPROGRAMMING CANCER RESEARCH
Product Name:TTNPB (Arotinoid Acid)
Synonyms:(E)-4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propen-1-yl)benzoic acid;(E)-4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid;RO 13-7410;TTNPB;(e)-openyl);6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propen-1-(e)-4-(2-(;(E)-4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl) benzoic acid;4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthenyl)-1E-propen-1-yl)benzoic acid
CAS:71441-28-6
MF:C24H28O2
MW:348.48
EINECS:
Product Categories:Inhibitors;pharmaceuticam intermediate;Intracellular receptor
Mol File:71441-28-6.mol
TTNPB (Arotinoid Acid) Structure
TTNPB (Arotinoid Acid) Chemical Properties
Melting point 242 °C
Boiling point 422.83°C (rough estimate)
density 1.0932 (rough estimate)
refractive index 1.4480 (estimate)
storage temp. -20°C
solubility chloroform/methanol: soluble9.80 - 10.20 mg/mL, clear, colorless to light yellow
form White solid
pka4.28±0.10(Predicted)
color White to Almost white
InChIInChI=1S/C24H28O2/c1-16(14-17-6-8-18(9-7-17)22(25)26)19-10-11-20-21(15-19)24(4,5)13-12-23(20,2)3/h6-11,14-15H,12-13H2,1-5H3,(H,25,26)/b16-14+
InChIKeyFOIVPCKZDPCJJY-JQIJEIRASA-N
SMILESC(O)(=O)C1=CC=C(/C=C(/C2=CC=C3C(=C2)C(C)(C)CCC3(C)C)\C)C=C1
CAS DataBase Reference71441-28-6
Safety Information
Hazard Codes T
Risk Statements 60-61-36/37/38
Safety Statements 53-26-36/37/39-45
WGK Germany 3
RTECS DH6834900
HS Code 2916.39.7900
Storage Class6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects
Hazard ClassificationsEye Irrit. 2
Repr. 1B
Skin Irrit. 2
STOT SE 3
MSDS Information
ProviderLanguage
SigmaAldrich English
TTNPB (Arotinoid Acid) Usage And Synthesis
DescriptionTTNPB (Arotinoid Acid) is a potent RAR agonist, and inhibits binding of [3H]tRA with IC50 of 5.1 nM, 4.5 nM, and 9.3 nM for human RARα, β, and γ, respectively.
Uses
  1. TTNPB is an analog of retinoic acid that potently and selectively activates retinoic acid receptors (RAR; EC50 = 21, 4, and 2.4 nM for RARα, RARβ, and RARγ, respectively; Beard et al.; Wong et al.).
  2. TTNPB has been used for transcriptional assays in 293T cells. It has also been used as a RAR-agonist in cultured human cord blood CD34+CD38-lin- cells.
  3. It does not act on retinoid X receptors and weakly agonizes farnesoid X receptor (EC50 > 1 µM).
  4. TTNPB is used to study RAR action in diverse processes, including epidermal cell proliferation, embryogenesis, and stem cell differentiation.
Biochemical ActionsSelective and highly potent retinoic acid analog with affinity for retinoic acid receptors (RAR) α, β, and γ, which are nuclear transcription factors. Produces ligand-activated transcription of genes that possess retinoic acid responsive elements.
In vitroTTNPB binds to nuclear retinoic acid receptors with high affinity, inhibits binding of [3H]tRA with IC50 of 3.8 nM, 4.0 nM, and 4.5 nM for mRARα, β, and γ, respectively. TTNPB increases transcriptional activation of Mouse RARs in JEG-3 cells after 72 h using conditioned media with EC50 of 2.0 nM, 1.1 nM and 0.8 nM for mRARα, β, and γ, respectively. TTNPB inhibits the growth of normal human mammary epithelial cells (HMECs) and estrogen receptor-positive (ER-positive) breast cancer cells by inducing G1 cell cycle blockade.  TTNPB causes a concentration-dependent decrease in ES-D3 cell differentiation.
In vivoTTNPB (0.25 mg/kg) causes growth inhibition in both MXT-HS and MXT-HI models by inducing cell apoptosis.
DIFFERENTIATION
  1. In combination with CHIR99021 or Activin A, induces intermediate mesoderm formation from human or mouse pluripotent stem cells, respectively (Araoka et al.; Oeda et al.).
  2. Promotes neuronal differentiation in cultured chick caudal neural plate explants (Diez del Corral et al.).
REPROGRAMMINGEnables chemical reprogramming (without genetic factors) of mouse embryonic fibroblasts to induced pluripotent stem (iPS) cells, in combination with CHIR99021, Tranylcypromine, Valproic Acid, 3-Deazaneplanocin A, and E-616452 (Hou et al.).
CANCER RESEARCHInduces the in vitro growth and differentiation to granulocytes of myeloid progenitors isolated from myelodysplastic syndrome (MDS) patients (Fabian et al.).
UsesTTNPB is an analog of retinoic acid that potently and selectively activates retinoic acid receptors.
DefinitionChEBI: A retinoid that consists of benzoic acid substituted at position 4 by a 2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl group. It is a synthetic retinoid that acts as a selective agonist for the retinoic acid receptors (RAR).
Biological ActivityExtremely potent analog of retinoic acid, selective for the retinoic acid receptor (RAR) subtype.
Biochem/physiol ActionsSelective and highly potent retinoic acid analog with affinity for retinoic acid receptors (RAR) α, β, and γ, which are nuclear transcription factors. Produces ligand-activated transcription of genes that possess retinoic acid responsive elements.
Safety ProfileAn experimental teratogen. Otherexperimental reproductive effects. When heated todecomposition it emits acrid smoke and irritating fumes.
Synthesis
ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid

71441-09-3

TTNPB (Arotinoid Acid)

71441-28-6

In a 10 mL single neck flask, 3 mL of dichloromethane, 558 mg of ethyl (E)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoate, 267 mg of p-ethoxycarbonylbenzaldehyde, and 16 mg of tetrabutylammonium bromide were added, and mixed by stirring. An aqueous solution of 200 mg sodium hydroxide and 400 mg sodium hydroxide was then added and heated to reflux. After 1 hour of reaction, the reaction progress was monitored by HPLC until the peak area ratio of ethyl (E)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoate, the intermediate (E)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoate was less than 5% and the reaction was stopped. The solvent was removed by evaporation under reduced pressure and 2 mL of ethanol, 250 mg of sodium hydroxide and 4 mL of water were added to the residue and heated to reflux with stirring. The reaction was continued for 1 hour and monitored by HPLC until the raw material (E)-ethyl 4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoate was completely consumed. After completion of the reaction, the reaction solution was cooled to 40°C with ice water, poured into 5 mL of water and the pH was adjusted to 2-6 with 0.5 N dilute sulfuric acid to precipitate a solid. The organic layer was separated by adding 20 ml of dichloromethane under stirring and washed sequentially with 2 x 10 ml of dichloromethane and 2 x 20 ml of deionized water. The organic layer was dried with 2 g of anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. Cooling to -10 °C induced precipitation of a white solid, the filter cake was washed with 0.5 mL of ethanol and dried under reduced pressure at 50 °C to afford the target product (E)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoic acid (279 mg, 80.1% yield, 99.1% HPLC purity, MS (MH+): 347.2).

storageDesiccate at -20°C
references[1] pignatello m a, kauffman f c, levin a a. multiple factors contribute to the toxicity of the aromatic retinoid, ttnpb (ro 13-7410): binding affinities and disposition. toxicology and applied pharmacology, 1997, 142(2): 319-327.
Tag:TTNPB (Arotinoid Acid)(71441-28-6) Related Product Information
TTP 22 TTK21 Belizatinib 4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)ethynyl)-benzoicacid 4-TERT-BUTYLSTYRENE Temarotene 1,1,4,4-Tetramethyl-1,2,3,4-tetrahydronaphthalene 4-Vinylbenzoic acid 4,4'-DIMETHYL-TRANS-STILBENE 1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene TTNPB (Arotinoid Acid) 4-FORMYL-TRANS-STILBENE TRANS-4-STILBENEMETHANOL 3-Methyl-TTNPB SMR 6 SMR 2 methylarotinoid arotinoic methanol